Trials / Conditions / AML, Adult Recurrent
AML, Adult Recurrent
6 registered clinical trials studyying AML, Adult Recurrent — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS NCT06704152 | BlueSphere Bio, Inc | Phase 1 / Phase 2 |
| Recruiting | Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML NCT06420063 | Essen Biotech | Phase 1 / Phase 2 |
| Recruiting | A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relaps NCT05829226 | PureTech | Phase 1 |
| Recruiting | A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients NCT05758610 | Shengke Pharmaceuticals (Jiangsu) Limited, China | Phase 1 |
| Completed | Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS NCT04901416 | Coeptis Therapeutics | Phase 1 |
| No Longer Available | Flotetuzumab Expanded Access Program NCT04678466 | MacroGenics | — |